Back to Trades
LINDAHL RICHARD S
EVPChief Financial OfficerCIK 0001196632
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Across 6 filings between 2025–2026, LINDAHL RICHARD S, EVP, Chief Financial Officer, has disclosed $3.7M in transactions — all concentrated in Emergent BioSolutions Inc. (EBS). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Jun 10 | EBS Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, Chief Financial Officer | Tax withheld | $31.7K |
| May 1 | EBS Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, Chief Financial Officer | Grant | $0 |
| Mar 6 | EBS Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, Chief Financial Officer | Other | $2.2M |
| Mar 5 | EBS Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, Chief Financial Officer | Award | $854.6K |
| Feb 10 | EBS Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, Chief Financial Officer | Tax withheld | $565.6K |
| Oct 17 | EBS Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, Chief Financial Officer | Tax withheld | $48.0K |
6 filings